Sun Wei, Li Fuxin, Wang Jue, Zheng Dexian, Gao Youhe
Proteomics Research Center, National Key Laboratory of Medical Molecular, Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical, Sciences, Beijing, People's Republic of China.
Mol Cell Proteomics. 2004 Dec;3(12):1194-9. doi: 10.1074/mcp.M400120-MCP200. Epub 2004 Oct 15.
Time-consuming and experience-dependent manual validations of tandem mass spectra are usually applied to SEQUEST results. This inefficient method has become a significant bottleneck for MS/MS data processing. Here we introduce a program AMASS (advanced mass spectrum screener), which can filter the tandem mass spectra of SEQUEST results by measuring the match percentage of high-abundant ions and the continuity of matched fragment ions in b, y series. Compared with Xcorr and DeltaCn filter, AMASS can increase the number of positives and reduce the number of negatives in 22 datasets generated from 18 known protein mixtures. It effectively removed most noisy spectra, false interpretations, and about half of poor fragmentation spectra, and AMASS can work synergistically with Rscore filter. We believe the use of AMASS and Rscore can result in a more accurate identification of peptide MS/MS spectra and reduce the time and energy for manual validation.
耗时且依赖经验的串联质谱手动验证通常应用于SEQUEST结果。这种低效的方法已成为MS/MS数据处理的重大瓶颈。在此,我们介绍一个程序AMASS(高级质谱筛选器),它可以通过测量高丰度离子的匹配百分比以及b、y系列中匹配碎片离子的连续性来筛选SEQUEST结果的串联质谱。与Xcorr和DeltaCn筛选器相比,AMASS可以增加来自18种已知蛋白质混合物生成的22个数据集中的阳性数量并减少阴性数量。它有效地去除了大多数噪声谱、错误解读以及约一半的碎片化不佳的谱图,并且AMASS可以与Rscore筛选器协同工作。我们相信使用AMASS和Rscore可以更准确地鉴定肽段MS/MS谱图,并减少手动验证的时间和精力。